Industrial Strength Bio Seminar Series
Monday, October 18, 2013
Seminar 12 Noon – 1:00 P.M. ~ 517 Bldg. – Lecture Hall
“Integrating Risk Management Into Drug Development”
- An understanding of how risk assessment and risk management should be integrated into drug development
- Discussion of approaches to safety signal assessment during drug development
- The basic considerations for risk management in drug development and ater approval
Paul R. Eisenberg, M.D., M.P.H., F.A.C.P., F.A.C.C.
Senior Vice President, Global Regulatory Affairs and Safety, Amgen
Dr. Eisenberg has been with Amgen since 2005, when he joined as Vice President, Global Safety, in Global Regulatory Affairs and Safety. He began his industry career in 1998 when he was Medical Director- Cardiovascular Therapeutic Area at Lilly Research Laboratories. Before joining Lilly, Dr. Eisenberg held increasingly more senior roles with Washington University School of Medicine in St. Louis. He holds an MD from New York Medical College.
Dress code: Business Casual
- Check the company at http://www.amgen.com
- Wear your name badges
- Ask questions
Contact information: Kathy McNevin, firstname.lastname@example.org